The AHSN Network has supported many innovators to help advance our health and care system. Find out more about successful innovations supported by the NHS.
Find your nearest AHSN
Improving medication safety in care homes using quality improvement methods
Marian House Nursing Home (located in Sutton Coldfield, Birmingham) successfully implemented a quality improvement project to improve the safety of medicines rounds for residents in their care.
Oxford Heartbeat’s medical device software PreSize® Neurovascular helps clinicians make surgical decisions with greater accuracy and confidence. Use of PreSize® is aimed at significantly reducing risks associated with stenting procedures, as clinicians are able to virtually test and compare the behaviour of stents in a patient’s cerebral blood vessels before surgery, selecting the best one for each patient.
Smart with your heart
Smart with your Heart aims to reduce readmissions in heart failure pathways by using digital technology. The aim was to reduce the 'revolving readmission door' for heart failure patients, by working in partnership with secondary and primary care settings and 3 digital providers.
PAD and PAWS: Peripheral Arterial Disease and Prevention, Assessment, Wound management, Self-care
This service improvement programme aims to enable primary care staff to improve lower limb vascular assessments in patients with leg ulcers to allow appropriate treatment to start earlier.
Pando is a communications platform for healthcare professionals, created by NHS doctors which helps NHS workers exchange patient information, make clinical decisions, manage their workload, and making collaboration easy, fast and secure. Pando saves healthcare professionals more than 40 minutes per shift and improves satisfaction at work, while saving NHS Trusts £6.9m over a 5-year term.
An aid to help medical staff to be able to read small print whilst wearing PPE, without the need for their usual reading glasses.
Electronic Repeat Dispensing (eRD)
WMAHSN are supporting GPs and pharmacists within the Midlands region to move patients to Electronic Repeat Dispensing (eRD). eRD offers a range of benefits such as reduced footfall to the GP practice and to the community pharmacy, supporting social distancing during COVID-19.
PINCER (pharmacist-led IT-based intervention to reduce clinically important medication errors)
PINCER is a proven pharmacist-led IT-based intervention to reduce clinically important medication errors in primary care. PINCER has been rolled out across the West Midlands region in 252 practices across the region. The was largest and quickest uptake of PINCER across the country and the project overachieved its 2 year target in 1 year.
SPACE QI Training
Safer Provision and Care Excellence (SPACE) is a new and exciting care home regional educational programme that has been rolled out across the West Midlands region.
Unique point of care blood test speeds up clinical decision-making, improves quality of care and reduces costs
A new point of care blood testing device is being introduced into frontline NHS services after an evaluation at three hospitals showed that it reduced A&E waiting times and helped clinicians make quicker decisions and get it right first time.
Thousands more pregnant women benefit from test to rule out pre-eclampsia following national rollout led by the Oxford AHSN
Quick, accurate blood tests which can help rule out pre-eclampsia are improving care for pregnant women and their unborn babies, reducing anxiety and saving the NHS money. AHSNs are leading a rapid adoption project for these tests into maternity units across the country. Rapid uptake means these tests are becoming available to thousands more pregnant women – up from 29,000 in March 2019 to a predicted 200,000+ by the end of December 2019. The award-winning NHS/research/industry partnership has been selected for the NHS England Accelerated Access Collaborative, Innovation Technology Payment and Rapid Uptake programmes in 2019/20 which introduce an accelerated pathway to market for highly transformative innovations.
CanSense and Dravya Discovery each receive £50,000 investment through Oxford AHSN Accelerator programme
The Oxford AHSN Accelerator programme, in collaboration with BioCity and regional partners from the NHS, industry and research within the Thames Valley, offers a launchpad for entrepreneurs and their ventures to move from idea to market. CanSense and Dravya Discovery won a place on the intensive eight-week programme and pitched to investors on the final day of the Accelerator programme in November 2019.